Cash and Short Term Investments (Quarterly) Chart

View Cash and Short Term Investments (Quarterly) for CRNX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash and Short Term Investments (Quarterly) Chart
Start Trial

Historical Cash and Short Term Investments (Quarterly) Data

View and export this data back to 2017. Start Trial.
Date Value
June 30, 2026 1.206B
March 31, 2026 1.291B
December 31, 2025 1.028B
September 30, 2025 1.093B
June 30, 2025 1.197B
March 31, 2025 1.275B
December 31, 2024 1.355B
September 30, 2024 862.67M
June 30, 2024 862.95M
March 31, 2024 900.96M
December 31, 2023 558.56M
September 30, 2023 554.65M
June 30, 2023 264.53M
March 31, 2023 296.12M
December 31, 2022 334.42M
September 30, 2022 368.36M
June 30, 2022 408.51M
March 31, 2022 319.72M
Date Value
December 31, 2021 333.71M
September 30, 2021 193.32M
June 30, 2021 203.76M
March 31, 2021 150.66M
December 31, 2020 170.88M
September 30, 2020 186.82M
June 30, 2020 205.16M
March 31, 2020 112.80M
December 31, 2019 118.39M
September 30, 2019 131.67M
June 30, 2019 144.97M
March 31, 2019 157.21M
December 31, 2018 163.88M
September 30, 2018 169.65M
June 30, 2018 68.41M
March 31, 2018 73.74M
December 31, 2017 14.19M

Cash and Short Term Investments Definition

Represents the sum of cash and short term investments.

Read full definition.

Cash and Short Term Investments (Quarterly) Range, Past 5 Years

View Cash and Short Term Investments (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash and Short Term Investments (Quarterly) Benchmarks

View Cash and Short Term Investments (Quarterly) Benchmarks
Start Trial
Vertex Pharmaceuticals, Inc. 7.863B
Johnson & Johnson 20.76B
Eli Lilly & Co. 8.95B
Bristol Myers Squibb Co. 11.07B
Corcept Therapeutics, Inc. 308.20M